Navigation Links
Voices Against Brain Cancer Discusses New Brain Tumor Vaccine HSPPC-96
Date:12/27/2013

New York, NY (PRWEB) December 27, 2013

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by Medical News Today that discusses a new brain cancer vaccine called HSPPC-96, which is personally molded to each patient’s genetic makeup.

According to the December 19th article published by Medical News Today titled “Promising results for personalized brain tumor vaccine,” patients with Gliobastoma Multiforme (GBM) brain tumors, when going through standard treatment, have a median survival rate of three to nine months. The new vaccine is developed specifically to each patient using his or her own respected tumor tissue. Investigators say the vaccine works by “prompting an immune system response unique to each patient, which sets out to kill any remaining tumor cells following surgery.”

The article states that 90 percent of patients lived after six months of treatment with this vaccine, while 30 percent lived after one year. However, more research is needed before receiving approval to use this treatment for GBM’s.

Researchers have to determine if the vaccine is safer and more effective when used alongside Avastin, a drug that is standard for therapy against GBM’s and known to reduce tumor size.

Michael Klipper, Chairman of Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, believes that with more research, this vaccine could be very helpful. “Evidently, additional extensive research has to be done with this vaccine. If results are consistently positive, this vaccine could be a game changer in the treatment of these deadly and aggressive brain tumors,” he says. “Regardless, the fact that this type of treatment is even a possibility, serves as a glimmer of hope for everyone in the brain cancer community.”

VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, Johns Hopkins, Memorial Sloan-Kettering and Yale, to name a few.

VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.

For press inquiries, please contact: 5W Public Relations.

#####

Read the full story at http://www.prweb.com/releases/2013/12/prweb11445639.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Voices Against Brain Cancer Hosts Contest on Facebook to Recognize Neurosurgeons and Nurses
2. Voices Against Brain Cancer Commends Baseball Coach’s Perseverance to Live a Full Life
3. National Voices for Equality, Education and Enlightenment (NVEEE) to Host 3rd Annual “Not on My Watch” VIP Reception Benefiting Bullying and Suicide Prevention Efforts
4. A New Website for Families to Turn: New Health and Wellness Promotion Website Launched by Family Voices
5. Voices Against Brain Cancer Commends 18-Year-Old Brain Cancer Patient for His Positive Outlook and Will to Live
6. Voices Against Brain Cancer to Host Annual “Join the Voices! Run/Walk” in Partnership with New York Road Runners
7. Voices Against Brain Cancer Commends Tech Startup Co-Founder for Positive Outlook Despite Grim Diagnosis
8. Voices Against Brain Cancer Commends Researchers for the Identification of an Important Protein that May Give Insight to More Effective Glioblastoma Treatments
9. Voices Against Brain Cancer Comments On Breakthrough Brain Surgery Technique
10. Redressing Past Wrongs: Changing the Common Rule to Increase Minority Voices in Research
11. Changing the common rule to increase minority voices in research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... California (PRWEB) , ... August 16, 2017 , ... An August 3rd article ... was the subject of a report in JAMA (the Journal of the American Medical Association). ... 50 were able to achieve BMIs under 30, when compared to patients with lower BMIs. ...
(Date:8/16/2017)... ... 16, 2017 , ... For the second year, the Brain ... educate the public on the impact of concussions. Brooke Mills, student and founder ... Awareness Day. , Brooke is working diligently is to raise awareness of concussion ...
(Date:8/16/2017)... Island, NY (PRWEB) , ... August 16, 2017 , ... ... with IV starts and blood draws. By broadly deploying AccuVein devices, Maury Regional Medical ... takes much of the guesswork out of a needle stick and more importantly, helps ...
(Date:8/16/2017)... YORK, NY (PRWEB) , ... August 16, 2017 , ... ... for better treatments and ultimately, a cure. , The grants are awarded through ... comprised of scientists with a wide array of backgrounds and expertise in all areas ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... eBook, 9781498499620    ) shares that during the time of a cancer diagnosis, surgery and ... God's love, and all the many ways God shows love to those who ...
Breaking Medicine News(10 mins):
(Date:7/31/2017)... Tenn. , July 31, 2017 Three Tru-D SmartUVC ... Yongsan, South Korea . Tru-D, short for "Total Room ... and operating rooms after an environmental services (ES) professional cleans the area ... ... "Although the ...
(Date:7/28/2017)... 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... ended June 30, 2017, and updated its financial outlook ... For the fiscal third quarter, Hill-Rom reported earnings ... diluted share in the prior-year period. These results reflect ... diluted share primarily related to the non-cash write-down of ...
(Date:7/27/2017)... WARSAW, Ind., July 27, 2017  Zimmer Biomet Holdings, ... the quarter ended June 30, 2017.  The Company reported ... of 1.1% over the prior year period, and an ... approximately 240 basis points of contribution from the LDR ... from the second quarter of 2016, or 0.3% on ...
Breaking Medicine Technology: